Device Trial Radar · NCT01494441
Pilot Study of rhBMP/BCP With or Without the TSRH® Spinal System for Posterolateral Lumbar Fusion in Patients With Degenerative Disc Disease
Last checked: Nov 19, 2026Latest source record: May 17, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
27
Actual
Start
May 1999
Primary completion
Mar 2003
Study completion Mar 2003
Sponsor
- Lead sponsor
- Medtronic Spinal and BiologicsPublic (MDT)
- Sponsor type
- Industry
- First posted
- Dec 19, 2011
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this pilot clinical trial is to evaluate both device designs (rhBMP-2/BCP and rhBMP-2/BCP/TSRH® spinal System) as methods of facilitating spinal fusion as compared to instrumented fusion with autograft in patients with symptomatic degenerative disc disease.
Conditions
- Degenerative Disc Disease
Interventions
rhBMP-2/BCPProcedure
The rhBMP-2/BCP device component consists of recombinant human Bone Morphogenetic Protein-2 ( rhBMP-2) and the biphasic calcium phosphate (BCP) carrier.
rhBMP-2/BCP/TSRH® Spinal SystemDevice
rhBMP-2/BCP device will be used in conjunction with the posterior spinal fixation system, the TSRH® Spinal System.
Autograft/TSRH® Spinal SystemDevice
The control device will be autogenous bone from the iliac crest of the patient used in conjunction with the TSRH® spinal System.
Primary outcomes
What the sponsor says the trial is designed to measure.
- FusionTime frame: 24 month
- Pain/Disability StatusTime frame: 24 month
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.